ÂÜÀòÂÒÂ×

Roshni Sacks has extensive work experience in the pharmaceutical industry. Most recently, they served as the Global Commercial Lead at Ultragenyx Pharmaceutical Inc. starting in May 2021. Prior to that, they held various roles at Pfizer, including Innovation Lead for Rare Disease Commercial Development - Duchenne Muscular Dystrophy Gene Therapy, Director for Rare Disease Commercial Development - Sickle Cell Disease, and Director Team Lead. Roshni also worked as a Senior Manager at Piper Jaffray and an Equity Research Associate at Rodman & Renshaw. Roshni began their career as a Senior Research Assistant at Columbia University.

Roshni Sacks obtained a Bachelor of Science degree in Biomedical Engineering from the University of Rochester, from 1997 to 2001. Following this, they pursued a Master of Science degree in Biomedical Engineering from Columbia University, from 2004 to 2006.